Fraunhofer-Gesellschaft

Publica

Hier finden Sie wissenschaftliche Publikationen aus den Fraunhofer-Instituten.
2020Alox12/15 Deficiency Exacerbates, While Lipoxin A4 Ameliorates Hepatic Inflammation in Murine Alcoholic Hepatitis
Queck, A.; Fink, A.F.; Sirait-Fischer, E.; Rüschenbaum, S.; Thomas, D.; Snodgrass, R.G.; Geisslinger, G.; Baba, H.A.; Trebicka, J.; Zeuzem, S.; Weigert, A.; Lange, C.M.; Brüne, B.
Journal Article
2020Capnography monitoring of non‐anesthesiologist provided sedation during percutaneous endoscopic gastrostomy placement: A prospective, controlled, randomized trial
Peveling-Oberhag, J.; Michael, F.; Tal, A.; Welsch, C.; Vermehren, J.; Farnik, H.; Grammatikos, G.; Lange, C.; Walter, D.; Blumenstein, I.; Filmann, N.; Herrmann, E.; Albert, J.; Zeuzem, S.; Bojunga, J.; Friedrich-Rust, M.
Journal Article
2020Tax1BP1 limits hepatic inflammation and reduces experimental hepatocarcinogenesis
Waidmann, O.; Pleli, T.; Weigert, A.; Imelmann, E.; Kakoschky, B.; Schmithals, C.; Döring, C.; Frank, M.; Longerich, T.; Köberle, V.; Hansmann, M.-L.; Brüne, B.; Zeuzem, S.; Piiper, A.; Dikic, I.
Journal Article
2019Omega-3 and -6 fatty acid plasma levels are not associated with liver cirrhosis-associated systemic inflammation
Schwarzkopf, K.M.; Queck, A.; Thomas, D.; Angioni, C.; Cai, C.; Freygang, Y.; Rüschenbaum, S.; Geisslinger, G.; Zeuzem, S.; Welsch, C.; Lange, C.M.
Journal Article
2019Pathophysiological role of prostanoids in coagulation of the portal venous system in liver cirrhosis
Queck, A.; Thomas, D.; Jansen, C.; Schreiber, Y.; Rüschenbaum, S.; Praktiknjo, M.; Schwarzkopf, K.M.; Mücke, M.M.; Schierwagen, R.; Uschner, F.E.; Meyer, C.; Clària, J.; Zeuzem, S.; Geisslinger, G.; Trebicka, J.; Lange, C.M.
Journal Article
2018Activation of Adenylyl Cyclase Causes Stimulation of Adenosine Receptors
Pleli, T.; Mondorf, A.; Ferreiros, N.; Thomas, D.; Dvorak, K.; Biondi, R.M.; Heringdorf, D.M.; Zeuzem, S.; Geisslinger, G.; Zimmermann, H.; Waidmann, O.; Piiper, A.
Journal Article
2018The portal vein as a distinct immunological compartment
Queck, A.; Rueschenbaum, S.; Kubesch, A.; Cai, C.; Zeuzem, S.; Weigert, A.; Brüne, B.; Nour-Eldin, A.; Gruber-Rouh, T.; Vogl, T.; Lange, C.M.
Journal Article
2017Camptothecin and its analog SN-38, the active metabolite of irinotecan, inhibit binding of the transcriptional regulator and oncoprotein FUBP1 to its DNA target sequence FUSE
Hosseini, S.K.; Kolterer, S.; Steiner, M.; Manstein, V. von; Gerlach, K.; Trojan, J.; Waidmann, O.; Zeuzem, S.; Schulze, J.O.; Hahn, S.; Steinhilber, D.; Gatterdam, V.; Tampé, R.; Biondi, R.M.; Proschak, E.; Zörnig, M.
Journal Article
2017Ongoing liver inflammation in patients with chronic hepatitis C and sustained virological response
Welsch, C.; Efinger, M.; Wagner, M. von; Herrmann, E.; Zeuzem, S.; Welzel, T.M.; Lange, C.M.
Journal Article
2015Telaprevir drug monitoring during antiviral therapy of hepatitis C graft infection after liver transplantation
Farnik, H.; Zimmermann, T.; Herrmann, E.; Bechstein, W.O.; Kronenberger, B.; Galle, P.R.; Labocha, S.; Ferreiros, N.; Geisslinger, G.; Zeuzem, S.; Sarrazin, C.; Welker, M.W.
Journal Article
2014Role of telaprevir plasma levels for predicting response to antiviral therapy in patients with hepatitis C virus genotype 1 infection
Farnik, H.; Ferreirós, N.; Labocha, S.; Geisslinger, G.; Zeuzem, S.; Sarrazin, C.; Vermehren, J.
Journal Article